Back to News
Market Impact: 0.2
aTyr Pharma, Inc. Announces 1-for-40 Reverse Stock Split
Source: Nasdaq
Company Fundamentals
aTyr Pharma filed an amendment to implement a 1-for-40 reverse split of its outstanding common stock. The excerpt says the amendment will take effect at 5:00 p.m. Eastern Time but cuts off before the effective date is complete.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.05
Ticker Sentiment
ATYR-0.20
More News
- aTyr Pharma announces 1-for-40 reverse stock split effective October 28
- SK Hynix third-quarter profit sharply beats estimates on AI memory boost
- SK Hynix Posts Record Profit Amid AI Rush
- Anthropic's IPO could be 'speculative fiction' or a 'generational moment' — investors are split
- Anthropic Gives Traders a Pure-Play Bet on Frontier AI
- VCs will make billions on Anthropic’s IPO, but Amazon is set to make much (much) more